Preliminary results of GRIPonMASH presented at the Innovations in SLD Think-Tank 2024

GRIPonMASH x Innovations in SLD Think-Tank 2024

On 3 and 4 May 2024 Vivian de Jong presented the GRIPonMASH project at the Innovations in SLD Think-Tank 2024 conference.

Vivian de Jong, PhD Candidate, UMC Utrecht & Scientific officer, Julius Clinical, presented the GRIPonMASH project. The SLD Think-Tank conference focuses on bridging gaps and innovating solutions in the diagnosis, prevention, and treatment of SLD (Steatotic Liver Disease).

Presenting the GRIPonMASH project where we aim to implement a patient care pathway in clinical practice and will work towards involving and educating primary care and non- hepatologists.
On the left José Willemse of Liver Patients International and on the right Vivian de Jong researcher for GRIPonMASH project

Poster presentation: preliminary results of GRIPonMASH

Vivian presented the GRIPonMASH project, which aims to implement a patient care pathway in clinical practice. The project will also work towards involving and educating primary care providers and non-hepatologists.

The subject of her poster presentation was: Paving the way for MASH screening of high risk patients in primary and secondary care: preliminary results of GRIPonMASH.

Vivian her poster presentation was a great succes and she got a lot of feedback and input from other attendees.

This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132946. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, Efpia, EuropaBio, MedTech Europe, Vaccines Europe and Mercodia Aktiebolag, Metadeq Limited and Julius Clinical Research BV. Funded by the European Union, the private members, and those contributing partners of the IHI JU.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them. www.ihi.europa.eu

Go back